tiprankstipranks
Advertisement
Advertisement
Chemours price target lowered to $18 from $21 at Morgan Stanley
PremiumThe FlyChemours price target lowered to $18 from $21 at Morgan Stanley
15d ago
Chemours downgraded to Neutral from Buy at UBS
Premium
The Fly
Chemours downgraded to Neutral from Buy at UBS
15d ago
Chemours price target lowered to $24 from $30 at Truist
Premium
The Fly
Chemours price target lowered to $24 from $30 at Truist
19d ago
Closing Bell Movers: SpaceX slips after first quarterly report as public company
PremiumThe FlyClosing Bell Movers: SpaceX slips after first quarterly report as public company
21d ago
Chemours sees Q3 revenue down 5% to flat, consensus $1.6B
Premium
The Fly
Chemours sees Q3 revenue down 5% to flat, consensus $1.6B
21d ago
Chemours sees FY26 revenue growth 1%-5% vs. FY25, consensus $6.05B
Premium
The Fly
Chemours sees FY26 revenue growth 1%-5% vs. FY25, consensus $6.05B
21d ago
NY AG sues 3M, Corteva, DuPont over toxic pollution from consumer products
PremiumThe FlyNY AG sues 3M, Corteva, DuPont over toxic pollution from consumer products
2M ago
Chemours price target lowered to $25 from $30 at Mizuho
Premium
The Fly
Chemours price target lowered to $25 from $30 at Mizuho
2M ago
Chemours Reaches Major PFAS Settlement and Compliance Agreement
Premium
Company Announcements
Chemours Reaches Major PFAS Settlement and Compliance Agreement
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100